Prévisions du marché européen des thérapies du microbiome jusqu’en 2030 – Analyse régionale – par type (thérapeutique et procédure), application (troubles métaboliques et obésité, infection à C. Difficile, maladie inflammatoire de l’intestin et autres) et utilisateur final (hôpitaux et cliniques, centres chirurgicaux ambulatoires , soins à domicile et autres)

Le marché européen des thérapies du microbiome était évalué à 97,74 millions de dollars américains en 2022 et devrait atteindre 212,52 millions de dollars américains d’ici 2030 ; on estime qu’il enregistrera un TCAC de 10,2 % de 2022 à 2030. L’afflux de fonds pour améliorer le pipeline de découverte du microbiome stimule l’Europe Le marché thérapeutique du microbiome La recherche a montré que les déséquilibres ou les perturbations du microbiome peuvent contribuer à diverses conditions, telles que les maladies inflammatoires de l’intestin et l\'obésité, ainsi que les troubles de santé mentale. La reconnaissance du rôle du microbiome dans la santé globale a suscité un intérêt significatif pour le développement de thérapies visant à cibler et à moduler le microbiome. De plus, les progrès de la technologie et des outils de recherche ont facilité l’étude et la manipulation du microbiome. Le séquençage de nouvelle génération et l’analyse métagénomique ont permis une compréhension plus approfondie des communautés microbiennes et de leurs fonctions. Les connaissances accrues ont ouvert de nouvelles possibilités pour développer des thérapies ciblées. Par exemple, en mars 2023, mbiomics GmbH, une société allemande de biotechnologie du microbiome, a développé la première génération de produits thérapeutiques efficaces basés sur le microbiome. Il a reçu un financement de 13 millions (15 millions de dollars) de MIG Capital. Le financement permettra de construire la plateforme, ce qui accélérera l’identification des premiers médicaments candidats et accélérera les efforts de recherche vers la validation clinique. À mesure que des preuves cliniques solides deviennent disponibles, les investisseurs commencent à s’intéresser aux entreprises de modulateurs du microbiome. Le financement accru fournit aux entreprises les ressources nécessaires pour surmonter les défis associés aux coûts élevés de développement et de production, faisant ainsi progresser le domaine. Aperçu du marché européen des produits thérapeutiques sur le microbiome Les sociétés de recherche thérapeutique sur le microbiome en Allemagne s\'efforcent d\'appeler d\'autres entreprises à investir dans leurs activités de recherche afin d\'améliorer la qualité de la recherche menée pour le développement de produits sur le microbiome. En mars 2023, mbiomics GmbH, une société de biotechnologie allemande axée sur le microbiome, a reçu environ 15 millions de dollars (13 millions) dans le cadre d\'un cycle de financement de série A mené par MIG Capital. mbiomics a utilisé les bénéfices pour se lancer dans des partenariats stratégiques, élargissant considérablement ses installations de laboratoire de Munich et ses équipes de R&D en Allemagne. Dans certaines procédures FMT, des agents infectieux peuvent être transférés du donneur au patient, ce qui affecte les résultats. Par conséquent, l’Allemagne a établi des réglementations particulières pour l’utilisation des procédures microbiologiques ou FMT. En Allemagne, les médicaments FMT sont réglementés comme des médicaments ; cependant, l\'utilisation de ce produit ne peut être effectuée que lorsqu\'aucun autre traitement n\'est efficace dans des conditions telles que les infections à C. difficile et les infections intestinales. Ainsi, malgré une recrudescence des investissements dans la recherche sur les thérapies du microbiome, les réglementations concernant l’utilisation de ces produits thérapeutiques pourraient entraver la croissance du marché européen des thérapies du microbiome en Allemagne. Chiffre d’affaires et prévisions du marché européen des thérapies pour le microbiome jusqu’en 2030 (en millions de dollars américains) Segmentation du marché européen des thérapies pour le microbiome Le marché européen des thérapies pour le microbiome est segmenté en fonction du type, de l’application, de l’utilisateur final et du pays. En fonction du type, le marché européen des thérapies du microbiome est divisé en thérapies et procédures. Le segment des procédures détenait une part plus importante en 2022. Le segment thérapeutique est en outre sous-segmenté en transplantation de microbiote fécal (FMT), prébiotiques et probiotiques, et autres. Par application, le marché européen des thérapies du microbiome est segmenté en troubles métaboliques et obésité, infection à C. difficile, maladie inflammatoire de l’intestin et autres. Le segment des troubles métaboliques et de l’obésité détenait la plus grande part en 2022. Par utilisateur final, le marché européen des thérapies du microbiome est constitué des hôpitaux et des cliniques, des centres de chirurgie ambulatoire, des soins à domicile et autres. Le segment des hôpitaux et des cliniques détenait la plus grande part en 2022. En fonction des pays, le marché européen des thérapies pour le microbiome est segmenté entre le Royaume-Uni, l’Allemagne, la France, l’Italie, l’Espagne et le reste de l’Europe. L\'Allemagne a dominé le marché européen des thérapies du microbiome en 2022. Caelus Health BV, Enterome SA, Ferring Holdings SA, Vedanta Biosciences Inc et YSOPIA Bioscience SA font partie des principales sociétés opérant sur le marché européen des thérapies du microbiome.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Microbiome Therapeutics Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

5. Europe Microbiome Therapeutics Market - Key Industry Dynamics

5.1 Europe Microbiome Therapeutics Market - Key Industry Dynamics

5.2 Key Market Drivers

5.2.1 Potential of Gut Microbiota in Maintaining Human Health

5.2.2 Inflow of Funds to Ameliorate Microbiome Discovery Pipeline

5.3 Key Market Restraints

5.3.1 High Cost of Development and Production

5.4 Key Market Opportunities

5.4.1 Increasing R&D to Gain Better Understanding of Human Microbiome

5.5 Key Future Trends

5.5.1 Technological Advancement in Human Microbiome Therapeutics

5.6 Impact of Drivers and Restraints:

6. Microbiome Therapeutics Market - Europe Market Analysis

7. Europe Microbiome Therapeutics Market Analysis - Type

7.1 Therapeutics

7.1.1 Overview

7.1.2 Therapeutics Market, Revenue and Forecast to 2030 (US$ Thousand)

7.2 Procedure

7.2.1 Overview

7.2.2 Procedure Market, Revenue and Forecast to 2030 (US$ Thousand)

8. Europe Microbiome Therapeutics Market Analysis - Application

8.1 Metabolic Disorder and Obesity

8.1.1 Overview

8.1.2 Metabolic Disorder and Obesity Market, Revenue and Forecast to 2030 (US$ Thousand)

8.2 C. Difficile Infection (CDI)

8.2.1 Overview

8.2.2 C. Difficile Infection (CDI) Market, Revenue and Forecast to 2030 (US$ Thousand)

8.3 Inflammatory Bowel Disease

8.3.1 Overview

8.3.2 Inflammatory Bowel Disease Market, Revenue and Forecast to 2030 (US$ Thousand)

8.4 Others

8.4.1 Overview

8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

9. Europe Microbiome Therapeutics Market Analysis - End User

9.1 Hospitals and Clinics

9.1.1 Overview

9.1.2 Hospitals and Clinics Market, Revenue and Forecast to 2030 (US$ Thousand)

9.2 Ambulatory Surgical Centers

9.2.1 Overview

9.2.2 Ambulatory Surgical Centers Market, Revenue and Forecast to 2030 (US$ Thousand)

9.3 Homecare

9.3.1 Overview

9.3.2 Homecare Market, Revenue and Forecast to 2030 (US$ Thousand)

9.4 Others

9.4.1 Overview

9.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

10. Europe Microbiome Therapeutics Market - Country Analysis

10.1. Europe Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.1 Europe Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.2 UK

10.1.2.1 UK: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.2.2 United Kingdom Europe Microbiome Therapeutics Market Breakdown by Type

10.1.2.2.1 UK: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.2.3 UK: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.2.4 UK: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.3 Germany

10.1.3.1 Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.3.2 Germany: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.3.2.1 Germany: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.3.3 Germany: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.3.4 Germany: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.4 France

10.1.4.1 France: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.4.2 France: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.4.2.1 France: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.4.3 France: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.4.4 France: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.5 Italy

10.1.5.1 Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.5.2 Italy: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.5.2.1 Italy: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.5.3 Italy: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.5.4 Italy: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.6 Spain

10.1.6.1 Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.6.2 Spain: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.6.2.1 Spain: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.6.3 Spain: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.6.4 Spain: Europe Microbiome Therapeutics Market Breakdown by End User

10.1.7 Rest of Europe

10.1.7.1 Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.7.2 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Type

10.1.7.2.1 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.7.3 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by Application

10.1.7.4 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown by End User

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in Europe Microbiome Therapeutics Market

12. Company Profiles

12.1 YSOPIA Bioscience SA

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Ferring Holdings SA

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Enterome SA

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Caelus Health BV

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Vedanta Biosciences Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. Europe Microbiome Therapeutics Market Segmentation

Table 2. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Type

Table 3. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Therapeutics

Table 4. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - Application

Table 5. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand) - End User

Table 6. Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Country

Table 7. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 8. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 9. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 10. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 11. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 12. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 13. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 14. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 15. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 16. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 17. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 18. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 19. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 20. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 21. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 22. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 23. ADULT OBESITY, 2030

Table 24. CHILD OBESITY, 2030

Table 25. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 26. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 27. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 28. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 29. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 30. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 31. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 32. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 33. Recent Growth Strategies in Europe Microbiome Therapeutics Market

Table 34. Glossary of Terms, Europe Microbiome Therapeutics Market

List of Figures

Figure 1. Europe Microbiome Therapeutics Market Segmentation, By Country

Figure 2. Europe PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Microbiome Therapeutics Market Revenue (US$ Thousand), 2022 - 2030

Figure 5. Europe Microbiome Therapeutics Market Share (%) - Type, 2022 and 2030

Figure 6. Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 7. Procedure Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 8. Europe Microbiome Therapeutics Market Share (%) - Application, 2022 and 2030

Figure 9. Metabolic Disorder and Obesity Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 10. C. Difficile Infection (CDI) Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 11. Inflammatory Bowel Disease Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 12. Others Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 13. Europe Microbiome Therapeutics Market Share (%) - End User, 2022 and 2030

Figure 14. Hospitals and Clinics Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 15. Ambulatory Surgical Centers Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 16. Homecare Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 17. Others Market Revenue and Forecasts To 2030 (US$ Thousand)

Figure 18. Europe Microbiome Therapeutics Market Breakdown by Key Countries - Revenue (2022) (US$ Thousand)

Figure 19. Europe Microbiome Therapeutics Market Breakdown by Key Countries, 2022 and 2030 (%)

Figure 20. UK: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 21. Germany: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 22. France: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 23. Italy: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 24. Spain: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 25. Rest of Europe: Europe Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

1. Caelus Health BV

2. Enterome SA

3. Ferring Holdings SA

4. Vedanta Biosciences Inc

5. YSOPIA Bioscience SA

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe microbiome therapeutics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in Europe microbiome therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the microbiome therapeutics market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3550

$2840

Site License

$4550

$3640

Enterprise License

$5550

$4440

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Get Free Sample For Europe Microbiome Therapeutics Market

WHAT'S INCLUDED IN FULL REPORT